Efficacy and Safety of Butylphthalide for Neurological Recovery After Cardiac Arrest: A Pilot Randomized Controlled Trial.

33.3% in the NBP group, p = 0.93), we observed a notable trend toward lower in‐hospital mortality in the NBP group (52.9% in the placebo group vs. 33.3% in the NBP group, p = 0.098), along with a substantial increase in the proportion of patients with a CPC score of 3 (5.9% in the placebo group vs. 16.7% in the NBP group) (Figure 2 ).

also in 2,380 other papers

Consequently, while we observed trends suggestive of therapeutic efficacy, these differences did not reach statistical significance, limiting its clinical applicability and highlighting the need for larger‐scale studies to further validate our findings.

also in 111,027 other papers